Literature DB >> 23000745

Quantum dots as a platform for nanoparticle drug delivery vehicle design.

Christine E Probst1, Pavel Zrazhevskiy, Vaishali Bagalkot, Xiaohu Gao.   

Abstract

Nanoparticle-based drug delivery (NDD) has emerged as a promising approach to improving upon the efficacy of existing drugs and enabling the development of new therapies. Proof-of-concept studies have demonstrated the potential for NDD systems to simultaneously achieve reduced drug toxicity, improved bio-availability, increased circulation times, controlled drug release, and targeting. However, clinical translation of NDD vehicles with the goal of treating particularly challenging diseases, such as cancer, will require a thorough understanding of how nanoparticle properties influence their fate in biological systems, especially in vivo. Consequently, a model system for systematic evaluation of all stages of NDD with high sensitivity, high resolution, and low cost is highly desirable. In theory, this system should maintain the properties and behavior of the original NDD vehicle, while providing mechanisms for monitoring intracellular and systemic nanocarrier distribution, degradation, drug release, and clearance. For such a model system, quantum dots (QDots) offer great potential. QDots feature small size and versatile surface chemistry, allowing their incorporation within virtually any NDD vehicle with minimal effect on overall characteristics, and offer superb optical properties for real-time monitoring of NDD vehicle transport and drug release at both cellular and systemic levels. Though the direct use of QDots for drug delivery remains questionable due to their potential long-term toxicity, the QDot core can be easily replaced with other organic drug carriers or more biocompatible inorganic contrast agents (such as gold and magnetic nanoparticles) by their similar size and surface properties, facilitating translation of well characterized NDD vehicles to the clinic, maintaining NDD imaging capabilities, and potentially providing additional therapeutic functionalities such as photothermal therapy and magneto-transfection. In this review we outline unique features that make QDots an ideal platform for nanocarrier design and discuss how this model has been applied to study NDD vehicle behavior for diverse drug delivery applications.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23000745      PMCID: PMC3541463          DOI: 10.1016/j.addr.2012.09.036

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  167 in total

1.  Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking.

Authors:  Maxime Dahan; Sabine Lévi; Camilla Luccardini; Philippe Rostaing; Béatrice Riveau; Antoine Triller
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

2.  Long-term exposure to CdTe quantum dots causes functional impairments in live cells.

Authors:  Sung Ju Cho; Dusica Maysinger; Manasi Jain; Beate Röder; Steffen Hackbarth; Françoise M Winnik
Journal:  Langmuir       Date:  2007-01-12       Impact factor: 3.882

3.  Water-dispersed near-infrared-emitting quantum dots of ultrasmall sizes for in vitro and in vivo imaging.

Authors:  Yao He; Yiling Zhong; Yuanyuan Su; Yimei Lu; Ziyun Jiang; Fei Peng; Tingting Xu; Shao Su; Qing Huang; Chunhai Fan; Shuit-Tong Lee
Journal:  Angew Chem Int Ed Engl       Date:  2011-05-09       Impact factor: 15.336

4.  Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection.

Authors:  Zeyu Xiao; Etgar Levy-Nissenbaum; Frank Alexis; Andrej Lupták; Benjamin A Teply; Juliana M Chan; Jinjun Shi; Elise Digga; Judy Cheng; Robert Langer; Omid C Farokhzad
Journal:  ACS Nano       Date:  2012-01-03       Impact factor: 15.881

5.  Reactive semiconductor nanocrystals for chemoselective biolabeling and multiplexed analysis.

Authors:  Travis L Jennings; Sara G Becker-Catania; Robert C Triulzi; Guoliang Tao; Bradley Scott; Kim E Sapsford; Samantha Spindel; Eunkeu Oh; Vaibhav Jain; James B Delehanty; Duane E Prasuhn; Kelly Boeneman; W Russ Algar; Igor L Medintz
Journal:  ACS Nano       Date:  2011-06-21       Impact factor: 15.881

6.  Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects.

Authors:  Weibo Cai; Dong-Woon Shin; Kai Chen; Olivier Gheysens; Qizhen Cao; Shan X Wang; Sanjiv S Gambhir; Xiaoyuan Chen
Journal:  Nano Lett       Date:  2006-04       Impact factor: 11.189

Review 7.  Nanoparticle-based theranostic agents.

Authors:  Jin Xie; Seulki Lee; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2010-08-04       Impact factor: 15.470

8.  Targeted cellular delivery of quantum dots loaded on and in biotinylated liposomes.

Authors:  Valeria Sigot; Donna J Arndt-Jovin; Thomas M Jovin
Journal:  Bioconjug Chem       Date:  2010-08-18       Impact factor: 4.774

9.  Combining chemoselective ligation with polyhistidine-driven self-assembly for the modular display of biomolecules on quantum dots.

Authors:  Duane E Prasuhn; Juan B Blanco-Canosa; Gary J Vora; James B Delehanty; Kimihiro Susumu; Bing C Mei; Philip E Dawson; Igor L Medintz
Journal:  ACS Nano       Date:  2010-01-26       Impact factor: 15.881

10.  One at a time, live tracking of NGF axonal transport using quantum dots.

Authors:  Bianxiao Cui; Chengbiao Wu; Liang Chen; Alfredo Ramirez; Elaine L Bearer; Wei-Ping Li; William C Mobley; Steven Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-14       Impact factor: 11.205

View more
  52 in total

Review 1.  The pharmacology of regenerative medicine.

Authors:  George J Christ; Justin M Saul; Mark E Furth; Karl-Erik Andersson
Journal:  Pharmacol Rev       Date:  2013-07-01       Impact factor: 25.468

2.  Multifunctional nanomedicines: potentials and prospects.

Authors:  Udita Agrawal; Madhu Gupta; Rajesh S Jadon; Rajeev Sharma; S P Vyas
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

Review 3.  Nanotechnology and its use in imaging and drug delivery (Review).

Authors:  Serjay Sim; Nyet Kui Wong
Journal:  Biomed Rep       Date:  2021-03-05

4.  Susceptibility to quantum dot induced lung inflammation differs widely among the Collaborative Cross founder mouse strains.

Authors:  David K Scoville; Collin C White; Dianne Botta; Lisa A McConnachie; Megan E Zadworny; Stefanie C Schmuck; Xiaoge Hu; Xiaohu Gao; Jianbo Yu; Russell L Dills; Lianne Sheppard; Martha A Delaney; William C Griffith; Richard P Beyer; Richard C Zangar; Joel G Pounds; Elaine M Faustman; Terrance J Kavanagh
Journal:  Toxicol Appl Pharmacol       Date:  2015-10-21       Impact factor: 4.219

5.  Evaluation of CdTe/CdS/ZnS core/shell/shell quantum dot toxicity on three-dimensional spheroid cultures.

Authors:  Mehriban Ulusoy; Antonina Lavrentieva; Johanna-Gabriela Walter; Franziska Sambale; Mark Green; Frank Stahl; Thomas Scheper
Journal:  Toxicol Res (Camb)       Date:  2015-08-07       Impact factor: 3.524

Review 6.  Recent advances in nanotherapeutic strategies for spinal cord injury repair.

Authors:  Young Hye Song; Nikunj K Agrawal; Jonathan M Griffin; Christine E Schmidt
Journal:  Adv Drug Deliv Rev       Date:  2018-12-22       Impact factor: 15.470

7.  Triblock copolymer-encapsulated nanoparticles with outstanding colloidal stability for siRNA delivery.

Authors:  Jian Qian; Xiaohu Gao
Journal:  ACS Appl Mater Interfaces       Date:  2013-01-15       Impact factor: 9.229

8.  Design of Thiol- and Light-sensitive Degradable Hydrogels using Michael-type Addition Reactions.

Authors:  Prathamesh M Kharkar; Kristi L Kiick; April M Kloxin
Journal:  Polym Chem       Date:  2015-08-21       Impact factor: 5.582

9.  Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy.

Authors:  Mingzhen Zhang; Bo Xiao; Huan Wang; Moon Kwon Han; Zhan Zhang; Emilie Viennois; Changlong Xu; Didier Merlin
Journal:  Mol Ther       Date:  2016-08-05       Impact factor: 11.454

10.  Gemcitabine-retinoid prodrug loaded nanoparticles display in vitro antitumor efficacy towards drug-resilient human PANC-1 pancreatic cancer cells.

Authors:  Hamilton Kakwere; Elizabeth S Ingham; Spencer K Tumbale; Katherine W Ferrara
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2020-07-04       Impact factor: 7.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.